Network metanalysis and cost-effectiveness of abiraterone, docetaxel or placebo plus androgen deprivation therapy (ADT) for hormone-sensitive advanced prostate cancer.

Pedro Nazareth Aguiar, Gilberto Lopes, Sarah Simko et al.|Journal of Clinical Oncology|2018

Cited by 7